(Q28304807)
Statements
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial (English)
0 references
26 February 2011
0 references
377
0 references
9767
0 references
721-31
0 references